Related Experiment Video

Updated: Jun 9, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

Genetic and epidemiological risk factors in the development of bronchopulmonary dysplasia

Beena Mailaparambil1, Marcus Krueger, Ulrike Heizmann

  • 1Centre for Pediatrics and Adolescent Medicine, University of Freiburg, Mathildenstrasse 1, Freiburg, Germany.

Disease Markers
|September 10, 2010
PubMed

Insights

Bronchopulmonary dysplasia (BPD) is a chronic lung disease in preterm infants. While clinical factors like birth weight are key, genetic links to BPD are complex and require further study.

Area of Science:

  • Neonatology
  • Genetics
  • Pulmonology

Background:

  • Bronchopulmonary dysplasia (BPD) is a significant complication of prematurity in infants.
  • Known clinical risk factors for BPD exist, and recent research has identified candidate genes.

Purpose of the Study:

  • To investigate clinical and genetic risk factors for BPD development in the German population.
  • To analyze associations between specific gene polymorphisms and BPD incidence.

Main Methods:

  • Recruitment of 155 preterm infants (gestational age ≤28 weeks) at a tertiary neonatal center.
  • Collection of clinical data from hospital charts for 47 infants who developed moderate to severe BPD.
  • Genotyping of 37 polymorphisms across 16 candidate genes in all infants.

Main Results:

  • Birth weight and gestational age were the strongest epidemiological risk factors for BPD.
  • Significant genetic associations were found with polymorphisms in Tumour necrosis factor alpha, Toll like receptor 10, and vascular endothelial growth factor.
  • Haplotype analyses also indicated associations with Tumour necrosis factor alpha and Toll like receptor 10.

Conclusions:

  • Clinical factors demonstrated a more convincing association with BPD than genetic polymorphisms.
  • The genetic complexity of BPD is highlighted, suggesting intricate gene-environment interactions.
  • Identifying predisposing genetic factors for BPD may be challenging due to these complex interactions.

Related Concept Videos

Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.